The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Lipid alterations in chronic liver disease and liver cancer
Open accessAbstract
Lipids are a complex and diverse group of molecules with crucial roles in many physiological processes, as well as in the onset, progression, and maintenance of cancers. Fatty acids and cholesterol are the building blocks of lipids, orchestrating these crucial metabolic processes. In the liver, lipid alterations are prevalent as a cause and consequence of chronic hepatitis B and C virus infections, alcoholic hepatitis, and non-alcoholic fatty liver disease and steatohepatitis. Recent developments in lipidomics have also revealed that dynamic changes in triacylglycerols, phospholipids, sphingolipids, ceramides, fatty acids, and cholesterol are involved in the development and progression of primary liver cancer. Accordingly, the transcriptional landscape of lipid metabolism suggests a carcinogenic role of increasing fatty acids and sterol synthesis. However, limited mechanistic insights into the complex nature of the hepatic lipidome have so far hindered the development of effective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–296 of 296
Lencioni, R. A., Marrero, J., Venook, A. P., Ye, S.-L., & Kudo, M. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02414.x · Cited by 67
Yao, Y., Sun, S., Wang, J., Fei, F., Dong, Z., Ke, A., He, R., Wang, L., Zhang, L., Ji, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3964 · Cited by 67
Promrat, K., Longato, L., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00815.x · Cited by 66
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma
Matteo, S. D., Nevi, L., Costantini, D., Overi, D., Carpino, G., Safarikia, S., Giulitti, F., Napoletano, C., Manzi, E., Rose, A. M. D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210077 · Cited by 66
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer
Rudalska, R., Harbig, J., Snaebjornsson, M. T., Klotz, S., Zwirner, S., Taranets, L., Heinzmann, F., Kronenberger, T., Förster, M., Cui, W., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00168-3 · Cited by 66
Expression and roles of fatty acid synthase in hepatocellular carcinoma
Qiwei, H., Li, T., Zhang, X., Gao, P., QIAO, P., Li, S., & Geng, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3484 · Cited by 65
Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease
Sang, C., Wang, X., Zhou, K., Sun, T., Bian, H., Gao, X., Wang, Y., Zhang, H., Jia, W. P., Liu, P., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00852 · Cited by 63
Israelsen, M. E., Kim, M. G., Suvitaival, T., Madsen, B. S., Hansen, C. D., Torp, N., Trôst, K., Thiele, M. S., Hansen, T. F., Legido‐Quigley, C., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100325 · Cited by 63
Targeting SphK2 reverses acquired resistance of Regorafenib in hepatocellular carcinoma
Shi, W., Zhang, S., Ma, D., Yan, D., Zhang, G., Cao, Y., Wang, Z., Wu, J., & Jiang, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00694 · Cited by 61
Ji, C., Shinohara, M., Vance, D., Than, T. A., Ookhtens, M., Chan, C., & Kaplowitz, N. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00666.x · Cited by 60
Kang, S., Huang, J., Lee, B.-K., Jung, Y., Im, E., Koh, J., & Im, D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.11.002 · Cited by 57
Rohrbach, T. D., Asgharpour, A., Maczis, M. A., Montefusco, D. J., Cowart, L. A., Bédossa, P., Sanyal, A. J., & Spiegel, S. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093799 · Cited by 57
Park, H. R., Yoo, M. Y., Seo, J. H., Kim, I. S., Kim, N. Y., Kang, J. Y., Cui, L., Lee, C., Lee, C., & Lee, H. S. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf801978r · Cited by 56
Uranbileg, B., Ikeda, H., Kurano, M., Enooku, K., Sato, M., Saigusa, D., Aoki, J., Ishizawa, T., Hasegawa, K., Kokudo, N., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149462 · Cited by 56
Gao, M., Sun, K., Guo, M., Gao, H., Liu, K., Yang, C., Li, S., & Liu, N. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0512-1 · Cited by 55
Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients
Cotte, A. K., Cottet, V., Aires, V., Mouillot, T., Rizk, M., Vinault, S., Binquet, C., de Barros, J.-P. P., Hillon, P., & Delmas, D. (2019) · Oncotarget · doi:10.18632/oncotarget.26738 · Cited by 55
Lu, Y., Chen, J., Huang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23494 · Cited by 54
p53 regulates lipid metabolism in cancer
Chen, L., & Wang, W. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.188 · Cited by 54
Diraison, F., Large, V., Brunengraber, H., & Beylot, M. (1998) · Diabetologia · doi:10.1007/s001250050892 · Cited by 52
Revisiting the Warburg Effect: Diet‐Based Strategies for Cancer Prevention
Tran, Q., Lee, H., Kim, C., Kong, G., Gong, N., Kwon, S. H., Park, J., Kim, S., & Park, J. (2020) · BioMed Research International · doi:10.1155/2020/8105735 · Cited by 52
Cho, Y., Cho, E. J., Yoo, J., Chang, Y. W., Chung, G. E., Jeong, S., Park, S. H., Han, K., Shin, D. W., & Yu, S. J. (2021) · Cancers · doi:10.3390/cancers13071599 · Cited by 52
Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
Pawar, P., Ma, L., Byon, C. H., Liu, H., Ahn, E.-Y. E., Jhala, N. C., Arnoletti, J. P., McDonald, J. M., & Chen, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1150 · Cited by 51
A Ceramide-binding C1 Domain Mediates Kinase Suppressor of Ras Membrane Translocation
Yin, X., Zafrullah, M., Lee, H., Haimovitz‐Friedman, A., FUKS, Z. Y., & Kolesnick, R. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000233248 · Cited by 51
Jones, J. G., Solomon, M. A., Sherry, A. D., Jeffrey, F. M. H., & Malloy, C. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e843 · Cited by 51
Ding, X., Chaiteerakij, R., Moser, C. D., Shaleh, H. M., Boakye, J., Chen, G., Ndzengue, A., Li, Y., Zhou, Y., Huang, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7914 · Cited by 51
Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis
Garrido, A., Kim, E., Teijeiro, A., Sánchez, P. S., Gallo, R., Nair, A., Montoya, M. M., Perna, C., Vicent, G. P., Muñoz, J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.019 · Cited by 51
Mendenhall, C. L. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39410-4 · Cited by 50
Ren, M., Xu, H., Xia, H., Tang, Q., & Bi, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00504-1 · Cited by 50
Wong, Y. J., Qiu, T.-Y., Ng, G. K., Zheng, Q., & Teo, E. K. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001478 · Cited by 48
Chen, S., Yan, L., Yu, L., Song, Y., Chen, X., Cao, Q., Han, Y. K., Chen, C., Tang, J., Fan, Z., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.379 · Cited by 48
Bile Acids Affect the Growth of Human Cholangiocarcinoma via NF-kB Pathway
Dai, J.-Q., Wang, H.-X., Dong, Y., Zhang, Y.-X., & Wang, J. (2013) · Cancer Investigation · doi:10.3109/07357907.2012.762781 · Cited by 47
Hepatocellular Carcinoma Associated Lipid Metabolism Reprogramming
Skill, N. J., Scott, R. E., Wu, J., et al. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.09.005 · Cited by 47
Cariello, M., Peres, C. M., Zerlotin, R., Porru, E., Sabbà, C., Roda, A., & Moschetta, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11549-7 · Cited by 47
Yuan, P., Mu, J., Wang, Z., Ma, S., Da, X., Song, J., Zhang, H., Yang, L., Li, J., & Yang, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03648-1 · Cited by 47
The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in China
Wu, Q., He, X., Yu, L., Liu, W., & Tao, L. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.1963 · Cited by 46
Yenilmez, B., Wetoska, N., Kelly, M., Echeverria, D., Min, K., Lifshitz, L., Alterman, J. F., Hassler, M. R., Hildebrand, S., DiMarzio, C., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.007 · Cited by 46
Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality
Thrift, A. P., Natarajan, Y., Liu, Y., & El‐Serag, H. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.046 · Cited by 45
Traussnigg, S., Halilbasic, E., Hofer, H., Munda, P., Stojaković, T., Fauler, G., Kashofer, K., Krššák, M., Wolzt, M., & Trauner, M. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01735-5 · Cited by 45
Konuma, K., Itoh, M., Suganami, T., Kanai, S., Nakagawa, N., Sakai, T., Kawano, H., Hara, M., Kojima, S., Izumi, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121528 · Cited by 44
Lozano, E., Monte, M. J., Briz, Ó., Hernández‐Hernández, Á., Bañales, J. M., Marı́n, J. J. G., & Macı́as, R. I. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.022 · Cited by 43
Petrick, J. L., McMenamin, Ú. C., Zhang, X., Zeleniuch‐Jacquotte, A., Wactawski‐Wende, J., Simon, T. G., Sinha, R. R., Sesso, H. D., Schairer, C., Rosenberg, L. A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0835-5 · Cited by 43
Zhou, Y., Zhong, L., Yu, S., Shen, W., Cai, C., & Yu, H. (2020) · Aging · doi:10.18632/aging.103082 · Cited by 42
Guo, W., Zhong, W. H., Hao, L., Dong, H., Sun, X., Yue, R., Li, T., & Zhou, Z. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.002 · Cited by 42
Fu, H., Tang, B., Lang, J., Du, Y., Cao, B., Jin, L., Fang, M., Hu, Z., Cheng, C., Liu, X., et al. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.585306 · Cited by 41
Cho, H. K., Kim, S. Y., Yoo, S. K., Choi, Y. H., & Cheong, J. (2014) · FEBS Journal · doi:10.1111/febs.12776 · Cited by 40
Zhang, X., Yang, Z., Shi, Z., Zhu, Z., Li, C., Du, Z., Zhang, Y., Wang, Z., Jiao, Z., Tian, X., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105775 · Cited by 40
Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma
Ismail, I. T., Elfert, A., Helal, M., Salama, I. A., El‐Said, H., & Fiehn, O. (2020) · Cancers · doi:10.3390/cancers13010088 · Cited by 40
Bosch, D. E., & Yeh, M. M. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.09.008 · Cited by 38
Teng, F., Jiang, J., Zhang, J., Yuan, Y., Li, K., Zhou, B., Zhou, X., Liu, W., Zhang, P., Liu, D., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154725 · Cited by 38
Tomacha, J., Dokduang, H., Padthaisong, S., Namwat, N., Klanrit, P., Phetcharaburanin, J., Wangwiwatsin, A., Khampitak, T., Koonmee, S., Titapun, A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.696961 · Cited by 38
Matsumoto, M., Yashiro, H., Ogino, H., Aoyama, K., Nambu, T., Nakamura, S., Nishida, M., Wang, X., Erion, D. M., & Kaneko, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228212 · Cited by 37
Zhang, B., Zhou, B., Xiao, M., Li, H., Guo, L., Wang, M.-X., Yu, S., & Ye, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01025 · Cited by 37
Berk, P. D., Zhou, S., & Bradbury, M. W. (2005) · PubMed · Cited by 35
Ramon‐Krauel, M., Pentinat, T., Bloks, V. W., Cebrià, J., Ribó, S., Pérez-Wienese, R., Vilà, M., Palacios‐Marin, I., Fernández-Pérez, A., Vallejo, M., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700717rr · Cited by 35
Teng, C., Hsieh, W., Yang, C.-W. W., Su, H., Tsai, T., Sung, W., Huang, W., & Su, I. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22266 · Cited by 34
Bae, J.-S., Park, J. M., Lee, J., Oh, B., Jang, S., Lee, Y. B., Han, Y.-M., Ock, C.-Y., Cha, J.-Y., & Hahm, K. (2016) · Metabolism · doi:10.1016/j.metabol.2016.10.002 · Cited by 34
You, B., Chen, L., Hsu, P.-H., Sung, P.-H., Hung, Y.-C., & Lee, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00269 · Cited by 34
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma
Zhou, Y., Tao, J., Calvisi, D. F., & Chen, X. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731709 · Cited by 34
Padthaisong, S., Phetcharaburanin, J., Klanrit, P., Li, J. V., Namwat, N., Khuntikeo, N., Titapun, A., Jarearnrat, A., Wangwiwatsin, A., Mahalapbutr, P., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00266-5 · Cited by 32
Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma
Yang, J., Tian, Y., Zheng, R., Li, L., & Qiu, F. (2019) · Oncology Letters · doi:10.3892/ol.2019.10399 · Cited by 31
Yasui, K., Harano, Y., Mitsuyoshi, H., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0133-8 · Cited by 30
Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES
for the ERCHIVES study team, Butt, A. A., Peng, Y., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1268-2 · Cited by 30
Alves‐Paiva, R. M., Kajigaya, S., Feng, X., Chen, J., Desierto, M. J., Wong, S. C., Townsley, D. M., Donaires, F. S., Bertola, A., Gao, B., et al. (2017) · Liver International · doi:10.1111/liv.13529 · Cited by 30
Chen, Y., Luo, S.-N., Dong, L., Liu, T., Shen, X., Zhang, N., & Liang, L. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03054-3 · Cited by 30
Li, Y., Li, T., Jin, Y., & Shen, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108950 · Cited by 29
Liu, X., Liu, X., Shi, Q., Fan, X., & Qi, K. (2021) · BMC Pediatrics · doi:10.1186/s12887-020-02487-x · Cited by 28
Liang, Q., Liu, H., Zhang, T., Jiang, Y., Xing, H., & Zhang, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00572h · Cited by 27
Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma
Lavu, S., Therneau, T. M., Harmsen, W. S., Mara, K. C., Wongjarupong, N., Hassan, M. A. M., Ali, H. A., Antwi, S. O., Giama, N. H., Miyabe, K., et al. (2020) · Hepatology · doi:10.1002/hep.31146 · Cited by 27
Kim, J.-H., Nagappan, A., Jung, D. Y., Suh, N., & Jung, M. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011085 · Cited by 27
Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B
Arain, S. Q., Talpur, F. N., Channa, N. A., Ali, M. S., & Afridi, H. I. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0683-y · Cited by 26
Hirose, Y., Nagahashi, M., Katsuta, E., Yuza, K., Miura, K., Sakata, J., Kobayashi, T., Ichikawa, H., Shimada, Y., Kameyama, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29144-9 · Cited by 26
Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α
Xu, A., Wang, B., Fu, J., Qin, W., Yu, T., Yang, Z., Lu, Q., Chen, J., Chen, Y., & Wang, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.024 · Cited by 26
Fu, K., Wang, C., Gao, Y., Fan, S., Zhang, H., Sun, J., Jiang, Y., Liu, C., Guan, L., Liu, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00276 · Cited by 26
Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met
Zhang, C., Sheng, L., Yuan, M., Hu, J., Meng, Y., Wu, Y., Chen, L., Yu, H., Li, S., Zheng, G., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114918 · Cited by 26
Sphingosine-1-phosphate Receptor-1 Promotes Vascular Invasion and EMT in Hepatocellular Carcinoma
Yokota, T., Nojima, H., Kuboki, S., Yoshitomi, H., Furukawa, K., Takayashiki, T., Takano, S., & Ohtsuka, M. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.11.044 · Cited by 25
The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma
Kaewlert, W., Sakonsinsiri, C., Namwat, N., Sawanyawisuth, K., Ungarreevittaya, P., Khuntikeo, N., Armartmuntree, N., & Thanan, R. (2018) · Hormones and Cancer · doi:10.1007/s12672-018-0349-2 · Cited by 24
Yoshida, T., Tsuchiya, A., Kumagai, M., Takeuchi, S., Nojiri, S., Watanabe, T., Ogawa, M., Itoh, M., Takamura, M., Suganami, T., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.099 · Cited by 23
Wang, Y., Wu, T., Hu, D., Weng, X., Wang, X., Chen, P., Luo, X., Wang, H., & Ning, Q. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m079533 · Cited by 22
Shen, X., Liang, X., Ji, X., You, J., Zhuang, X., Song, Y., Yin, H., Zhao, M., & Zhao, L. (2021) · Food & Function · doi:10.1039/d1fo01472b · Cited by 22
Ding, H., Liu, J., Wang, C., & Su, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01520-4 · Cited by 21
Cerulenin Blockade of Fatty Acid Synthase Reverses Hepatic Steatosis in ob/ob Mice
Cheng, G., Palanisamy, A. P., Evans, Z. P., Sutter, A. G., Jin, L., Singh, I., May, H. D., Schmidt, M. G., & Chavin, K. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075980 · Cited by 20
Zheng, H. X., Chen, M., Lu, S., Zhao, L., Ji, J., & Gao, H. (2017) · Metabolomics · doi:10.1007/s11306-017-1260-5 · Cited by 20
Triclosan down-regulates fatty acid synthase through microRNAs in HepG2 cells
Sun, D., Zhao, T., Long, K., Wu, M., & Zhang, Z. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174261 · Cited by 20
DGAT2 stability is increased in response to DGAT1 inhibition in gene edited HepG2 cells
McFie, P. J., Chumala, P., Katselis, G. S., & Stone, S. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158991 · Cited by 20
Sun, J., Zhao, Y., Qin, L., Li, K., Zhao, Y., Sun, H., Zhang, T., & Zhang, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01069 · Cited by 19
Ding, X., Zhang, Y., Huang, T., Xu, G., Peng, C., Chen, G., Kong, B., Frieß, H., Shen, S., Lv, Y., et al. (2019) · Europe PMC (PubMed Central) · Cited by 18
Vlock, E., Karanjit, S., Talmon, G., & Farazi, P. (2020) · Journal of Cancer · doi:10.7150/jca.48495 · Cited by 18
Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma
Haberl, E. M., Weiß, T. S., Peschel, G., Weigand, K., Köhler, N., Pauling, J. K., Wenzel, J. J., Höring, M., Krautbauer, S., Liebisch, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105297 · Cited by 18
Yoneda, M., Endo, H., Nozaki, Y., Tomimoto, A., Fujisawa, T., Fujita, K., Yoneda, K., Takahashi, H., Saito, S., Iwasaki, T., et al. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070063 · Cited by 17
Shimizu, Y., Tamura, T., Kemmochi, A., Owada, Y., Ozawa, Y., Hisakura, K., Matsuzaka, T., Shimano, H., Nakano, N., Sakashita, S., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15239 · Cited by 16
The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver
Shi, Y., Wei, Q., Liu, Y., & Yuan, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.060 · Cited by 14
Distribution and clinical relevance of phospholipids in hepatocellular carcinoma
Liu, Z., Zhang, Z., Mei, H., Mao, J., & Zhou, X. (2020) · Hepatology International · doi:10.1007/s12072-020-10056-8 · Cited by 13
Luna, A. C. D. L., & Forti, F. L. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04167-5 · Cited by 11
Nemoto, N., Suzuki, S., Kikuchi, H., Okabe, H., Sassa, S., & Sakamoto, S. (2009) · PubMed · Cited by 9
Chang, S., Sung, P. S., Lee, J., Park, J., Shin, E., & Choi, C. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12685 · Cited by 5
Miranda, J. F., Scarinci, L. D., Ramos, L. F., da Silva, C. M., Gonçalves, L. R., de Morais, P. F., Malaspina, O., & Moraes, K. C. M. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22413 · Cited by 4
Cited by
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“High-cholesterol diets induce HCC in mice, partly through dysregulation of metabolism and calcium signaling [55–57].”
BackgroundKohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
Xiao, M.-Y., Pei, W.-J., Li, S., Li, F.-F., Xie, P., Luo, H.-T., Hyun Yoo, H., & Piao, X.-L. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107539 · Cited by 26
Metadata
- Authors
- Paul, B., Lewinska, M., & Andersen, J. B.
- Venue
- JHEP Reports
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 4
- Issue
- 6
- Pages
- 100479
- ISSN
- 2589-5559 (ISSN-L)
- OpenAlex
- W4220874523
- Cited by
- 308
- References
- 296
- FWCI
- 23.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.